Tony Coles is chairman and CEO of Yumanity Therapeutics, a biotechnology company transforming drug discovery for neurodegenerative diseases caused by protein misfolding. He also serves as chairman and CEO of TRATE Enterprises. Prior to Yumanity, Dr. Coles held executive and board positions at Onyx Pharmaceuticals, NPS Pharmaceuticals, Vertex Pharmaceuticals, Bristol-Myers Squibb, and Merck & Co. Dr. Coles now serves on the boards of several organizations, including McKesson Corporation, Regeneron Pharmaceuticals, the Council on Foreign Relations, Johns Hopkins University, and Johns Hopkins Medicine, the Metropolitan Museum of Art, and the Harvard Medical School Advisory Board. He is also a member of the council for the Smithsonian’s National Museum of African American History and Culture.
After receiving his bachelor’s degree from Johns Hopkins University, Dr. Coles earned his MD from Duke University and his MS in public health from Harvard University.